Research & Development

男人天堂2018无码手机男人天堂2018手机亚洲 丁香五月啪啪-激情综合“东部经济走廊”积极对接"一带一路" 中泰投资火热


  阿嬌要的水池自然不會是一般的泥水坑……地下不能滲水,不能硌腳,邊上不能有泥土弄髒身子……最重要的是還必須漂亮!   “總要試過才知道。”男人天堂2018无码手机   雲瑯笑的很溫暖,聲音也變得柔和,阿嬌不知道想起了什麼,看著雲瑯噗嗤一聲笑了起來,很有些花枝亂顫的意思。男人天堂2018手机亚洲   長長的甬道似乎沒有盡頭,太宰的呼吸早就變得急促起來,他的腳下卻不敢稍有停留,腳在每一塊必須踏足的石板上一沾就走,如同舞蹈一般。丁香五月啪啪-激情综合   “可以遏制我的貪欲!我已經用刀子幫你挑開了一條縫隙,你要是想看,掀開蓋子就成。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo